Tonia Poteat1, Sari L Reisner, Anita Radix. 1. aDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland bThe Fenway Institute, Fenway Health cDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA dCallen-Lorde Community Health Center, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: Recent data on the high burden of HIV among transgender women have stimulated interest in addressing HIV in this vulnerable population. This review situates the epidemiologic data on HIV among transgender women in the context of the social determinants of health and describes opportunities for effective interventions. RECENT FINDINGS: Transgender women experience unique vulnerability to HIV that can be attributed to multilevel, intersecting factors that also influence the HIV treatment and care continuum. Stigma and discrimination, lack of social and legal recognition of their affirmed gender, and exclusion from employment and educational opportunities represent fundamental drivers of HIV risk in transgender women worldwide. SUMMARY: Interventions to improve engagement in HIV prevention, testing, care, and treatment among transgender women should build on community strengths and address structural factors as well as psychosocial and biologic factors that increase HIV vulnerability and prevent access to HIV services.
PURPOSE OF REVIEW: Recent data on the high burden of HIV among transgender women have stimulated interest in addressing HIV in this vulnerable population. This review situates the epidemiologic data on HIV among transgender women in the context of the social determinants of health and describes opportunities for effective interventions. RECENT FINDINGS: Transgender women experience unique vulnerability to HIV that can be attributed to multilevel, intersecting factors that also influence the HIV treatment and care continuum. Stigma and discrimination, lack of social and legal recognition of their affirmed gender, and exclusion from employment and educational opportunities represent fundamental drivers of HIV risk in transgender women worldwide. SUMMARY: Interventions to improve engagement in HIV prevention, testing, care, and treatment among transgender women should build on community strengths and address structural factors as well as psychosocial and biologic factors that increase HIV vulnerability and prevent access to HIV services.
Authors: Alfonso Silva-Santisteban; H Fisher Raymond; Ximena Salazar; Jana Villayzan; Segundo Leon; Willi McFarland; Carlos F Caceres Journal: AIDS Behav Date: 2012-05
Authors: Larry Nuttbrock; Walter Bockting; Andrew Rosenblum; Sel Hwahng; Mona Mason; Monica Macri; Jeffrey Becker Journal: Am J Public Health Date: 2012-06-14 Impact factor: 9.308
Authors: Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax Journal: PLoS One Date: 2010-06-10 Impact factor: 3.240
Authors: Gabriela B Gomez; Annick Borquez; Carlos F Caceres; Eddy R Segura; Robert M Grant; Geoff P Garnett; Timothy B Hallett Journal: PLoS Med Date: 2012-10-09 Impact factor: 11.069
Authors: Sari L Reisner; Amaya G Perez-Brumer; Sarah A McLean; Javier R Lama; Alfonso Silva-Santisteban; Leyla Huerta; Jorge Sanchez; Jesse L Clark; Matthew J Mimiaga; Kenneth H Mayer Journal: AIDS Behav Date: 2017-12
Authors: Sheri A Lippman; Lissa Moran; Jae Sevelius; Leslie S Castillo; Angel Ventura; Sarah Treves-Kagan; Susan Buchbinder Journal: AIDS Behav Date: 2016-04
Authors: Ronnye Rutledge; Olga Morozova; Britton A Gibson; Frederick L Altice; Adeeba Kamarulzaman; Jeffrey A Wickersham Journal: LGBT Health Date: 2018-11-27 Impact factor: 4.151